09/01/2020 |
| Investments in proteogenomics research will enable additional molecular diagnostics and imaging technologies to enhance the molecular picture of cancer. The more information they have, the better equipped researchers and doctors are to identify treatments that will improve outcomes for patients. |
No hay comentarios:
Publicar un comentario